Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Return on Equity (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Return on Equity for 5 consecutive years, with 0.72% as the latest value for Q4 2025.

  • For Q4 2025, Return on Equity fell 6.0% year-over-year to 0.72%; the TTM value through Dec 2025 reached 0.72%, down 6.0%, while the annual FY2025 figure was 0.58%, 3.0% down from the prior year.
  • Return on Equity hit 0.72% in Q4 2025 for Kezar Life Sciences, down from 0.7% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.22% in Q3 2022 and bottomed at 0.73% in Q2 2025.
  • Average Return on Equity over 5 years is 0.48%, with a median of 0.5% recorded in 2023.
  • Year-over-year, Return on Equity grew 10bps in 2022 and then dropped -28bps in 2024.
  • Kezar Life Sciences' Return on Equity stood at 0.35% in 2021, then grew by 29bps to 0.25% in 2022, then crashed by -105bps to 0.5% in 2023, then tumbled by -32bps to 0.67% in 2024, then fell by -8bps to 0.72% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.72%, 0.7%, and 0.73% for Q4 2025, Q3 2025, and Q2 2025 respectively.